IMM 1.27% 40.0¢ immutep limited

american society of clinical oncology (asco), page-2

  1. 4,906 Posts.
    lightbulb Created with Sketch. 343

    Here you go gogo......

    Prima Newsletter 17/2/1012


    ""Prima BioMed will again be well represented at the American Society of Clinical Oncology conference in
    Chicago, in June. The conference is a major annual event for those in the oncology field of medicine, and is attended by some of the world’s leading oncologists.
    At this year’s conference, Dr Jonathan
    Berek from the Stanford Cancer Institute,
    Stanford University School of Medicine in California, will present a CANVAS study design, protocol and update on global recruitment, and Dr Jeffrey Goh from the Royal Brisbane Womens Hospital in Queensland, Australia, will make a presentation on the interim safety data from the CVac™ Phase IIb study. Prima’s Chief Medical Officer, Dr Neil Frazer, will again attend the conference. Dr Frazer made a presentation at last year’s event on the progress of the clinical trials process for CVac™""

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
0.005(1.27%)
Mkt cap ! $581.0M
Open High Low Value Volume
38.5¢ 41.0¢ 38.5¢ $1.351M 3.389M

Buyers (Bids)

No. Vol. Price($)
1 16911 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
40.5¢ 154170 1
View Market Depth
Last trade - 16.10pm 03/09/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.